参考文献/References:
[1] 赵小丽,王 倩,吴小玲,等.宫腔镜下行电切术结合刮宫术治疗多发性子宫内膜息肉近远期疗效临床观察[J].陕西医学杂志,2018,47(6):748-750.
[2] 王 丽,朱红英,张群昌.宫腔镜联合曼月乐手术治疗子宫内膜息肉疗效观察[J].陕西医学杂志,2019,48(7):920-922.
[3] Abro MSP.AAGL practice report:Practice guidelines for the diagnosis and management of endometrial polyps[J].Journal of minimally invasive gynecology,2012,19(1):3-10.
[4] Yaron H,Ido E,Hen Y,et al,Ronit Haimov-Kochman.The clinical significance of small endometrial polyps[J].European Journal of Obstetrics and Gynecology,2013,170(2):153-158.
[5] Wong M,Crnobrnja B,Liberale V,et al.The natural history of endometrial polyps[J].Human reproduction(Oxford,England),2017,32(2):236-239.
[6] 夏美琪,桂 涛,黄美华,等.子宫内膜息肉发病机制研究进展[J].广西医学,2019,41(15):1958-1961.
[7] 付 熙,张晓荣,丁 岩.左炔诺孕酮宫内缓释系统预防子宫内膜息肉复发的应用[J].中国计划生育学杂志,2017,25(9):621-623.
[8] 吴国荧,李琼珍.左炔诺孕酮宫内缓释系统与孕三烯酮预防功能性子宫内膜息肉复发的效果分析[J].首都食品与医药,2020,27(14):46-47.
[9] 李 燕,王 娟,张仁琦.促性腺激素释放激素与地屈孕酮片预防子宫内膜息肉电切术后复发的临床对比研究[J].中国医药导报,2020,17(14):86-89.
[10] Onathan SMJ,Malcolm GM.Indications and alternatives to hysterectomy[J].Clinical Obstetrics and Gynecology,2014,57(1):34-36.
[11] 黄素艳,陈航华,沈小洁.妈富隆辅助宫腔镜电切术治疗子宫内膜息肉的临床研究[J].现代诊断与治疗,2019,30(19):3404-3405.
[12] 侯彩莉,杨春娜,邢汝月.屈螺酮炔雌醇片联合宫腔镜电切术治疗子宫内膜息肉患者的临床研究[J].青岛医药卫生,2019,51(1):62-64.
[13] Cai HL,Ding XC,Qian RR,et al.Effects of levonorgestrel intrauterine system on endometrial tissue after endometrial polyps resection by hysteroscopy[J].Zhonghua Yixue Zazhi,2012,92(3):489-455.
[14] Sletten ET,Arnes M,Vereide AB,et al.Intrauterine progestin therapy as a new approach to premalignant endometrial polyps:A prospective observational study[J].Anticancer Research,2019,39(9):1536-1539.
[15] 李经纬,顾荣华,王颖娴,等.宫腔镜电切术联合LNG-IUS治疗子宫内膜息肉效果及炎症因子变化[J].中国计划生育学杂志,2020,28(6):823-826.
[16] 辛泽丽.左炔诺孕酮宫内节育系统(曼月乐)对凝血、纤溶功能的影响[D].太原:山西医科大学,2018.
[17] Gao WL,Zhang LP,Li WJ,et al.Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women[J].European Journal of Obstetrics and Gynecology,2012,161(1):23-28.
[18] Jesus SJL,Ana G,San M,et al.Effectiveness of transcervical hysteroscopic endometrial resection based on the prevention of the recurrence of endometrial polyps in post-menopausal women[J].BMC Women's Health,2015,15(1):13-19.
[19] Eken MK,Kaygusuz EI.Endometrial malignancies arising on endometrial polyps and precursor lesions[J].European Journal of Gynaecological oncology,2016,37(6):1325-1328.
[20] 田 超.子宫内膜息肉中医证素特征及其ER、PR、TLR4/MyD88/NF-κB的表达[D].广州:广州中医药大学,2016.
[21] 李雅静,夏亲华.基于数据对子宫内膜息肉中医用药规律分析[J].天津中医药,2018,35(3):179-181.
[22] 莫 琼,郝二伟,覃文慧,等.平性活血化瘀中药物质基础与药理作用的研究进展[J].中国实验方剂学杂志,2020,26(1):205-216.
[23] 龚 巍,王新梅,芦艳丽,等.生化汤加减对子宫内膜息肉术后患者月经经期、血清卵泡刺激素、黄体生成激素水平及复发率的影响[J].河北中医,2018,40(12):1819-1821.
[24] 林 晶,张宜群.中药化瘀散结法对降低子宫内膜息肉患者宫腔镜术后复发的临床研究[J].中华全科医学,2018,16(6):946-948,960.
[25] 蒋 婴,钱旭武,张宜群.化瘀散结法对子宫内膜息肉患者Ki-67、Bcl-2表达的影响[J].中国中医药科技,2018,25(1):11-14.
[26] 刘恒炼,王加俊,夏 敏.夏敏治疗子宫内膜息肉心得[J].中医临床研究,2017,9(36):56-58.
[27] 曾苑玲,纪 珮,谢金兰.中西医结合治疗痰湿瘀滞型子宫内膜息肉40例临床观察[J].中国民族民间医药,2019,28(11):102-104.
[28] 纪 珮,李丹虹,陈小平,等.宫腔镜手术联合苍附导痰汤加减治疗子宫内膜息肉合并不孕患者的生殖预后情况观察[J].中国医学创新,2019,16(10):78-80.
[29] 王 梅,魏绍斌.魏绍斌教授治疗子宫内膜息肉经验[J].世界最新医学信息文摘,2017,17(95):175-176.
[30] 薛勤梅,张晋峰,赵亚妮.加味清经散预防子宫内膜息肉术后复发的临床观察[J].中国民间疗法,2018,26(9):23-25.
[31] 向丽娟,曾 根.消癥汤预防子宫内膜息肉宫腔镜术后复发的临床研究[J].现代中西医结合杂志,2020,29(5):542-544,552.
[32] 樊聪俐.基于数据挖掘方法对妇科名家治疗癥瘕用药规律的研究[D].成都:成都中医药大学,2019.
[33] 郭菊清,牟重临.梅杞散治疗子宫内膜息肉临床体会[J].浙江中医杂志,2018,53(4):299-300.
[34] 曹天澈,陆启滨,陈 聪.补肾活血中药防治免疫复发性流产研究进展[J].中医学报,2019,34(12):2554-2557.